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rTMS to treat social anxiety disorder: a case report
Letter to the Editors
Dear Editor, 
Social anxiety disorder (SAD) is one of the most common and 
debilitating types of anxiety disorders. Nevertheless, little at-
tention has been dedicated to the study of the neurobiology 
underlying SAD until the last decade.1 Approximately 25% of 
anxiety disorder patients, including SAD patients, are non-
responders to traditional methods of treatment.2 Thus, advances 
in our understanding of the neural basis involved in SAD could 
lead to new therapeutic options.1 One such novel therapeutic 
option is repetitive transcranial magnetic stimulation (rTMS), a 
QRQLQYDVLYHSURFHGXUHZKHUHE\DSXOVHGPDJQHWLFÀHOGVWLPX-
lates electrical activity in the brain and depolarizes neurons.2 
We report a case of a 38 year old single male. The patient signed 
a consent form and was aware of the experimental protocol 
(approved by the Ethics Committee at Universidade Federal do 
Rio de Janeiro) before participation commenced. 
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in public), without comorbidities according to DSM-IV-TR.
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reuptake inhibitor (SSRI) and cognitive behavior therapy 
(CBT). A single session of rTMS was administered at 1Hz 
(inhibitory frequency) at 120% MT for 25 min (1,500 pulses) 
over the right ventromedial prefrontal cortex (vmPFC). 
The vmPFC represents the most promising target for rTMS 
because this structure is consistently activated in SAD.1 The 
right vmPFC is located near the Fp2 position according to an 
EEG-international 10/20 electrode scalp positioning system. 
Through this system, satisfactory activation of cortical areas 
may be reached reliably on a larger scale.3
Assessments were carried out pre- and post-treatment 
using the Beck Depression Inventory (BDI), Beck Anxiety 
Inventory (BAI) and Social Skills Inventory (SSI). Pre-treatment 
results were the following: BDI 18 (moderate), BAI 21 (mod-
erate). Post-treatment results were the following: BDI 19 
(moderate), BAI 5 (minimal). At a 2-month follow-up, we ob-
tained the following results: BDI 13 (minimal) and BAI 13 (mild) 
(Figure 1A). With respect to SSI, there were changes in social 
skill performance in 12 (8 positives and 4 negatives) of 32 issues 
between the pre-treatment and the post-treatment periods and 
in 16 (10 positives and 6 negatives) of 32 issues between the 
post-treatment and the follow-up periods (Figure 1B). 
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Figure 1 Scores of Beck Depression Inventory (BDI), Beck Anxiety 
Inventory (BAI) and Social Skills Inventory (SSI) related to rTMS ap-
plication. (A) Scores of BDI and BAI at pre- and post-treatment and 
at follow-up. (B) Scores of positive and negative responses to SSI at 
post-treatment and follow-up.
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Discussion
Prior to the rTMS session, the patient presented a moder-
ate level of anxiety, reporting for example, an inability to 
relax, nervousness, and a fear of the worst happening (areas 
most highly rated on BAI). One week after the rTMS session, 
the patient showed large reduction in anxiety symptoms 
compared to pre-treatment. With regard to social skills perfor-
mance, the patient showed a mild reduction post-treatment 
compared to pre-treatment. The patient reported a greater 
likelihood to join conversations, to have a sense of humor, 
and to offer help to peers (areas most highly rated on SSI). 
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area responsible for emotional regulation)4 promoted the 
reinterpretation and reprocessing of events regarding 
the patient’s anxiety level and social skills performance 
in a more controlled and therapeutic manner. During the 
two-month follow-up, the patient still presented low-level 
anxiety and similar social skills performance compared to pre-
treatment with a slight increase compared to post-treatment. 
However, without a placebo control, these assumptions are 
merely speculative at this point.
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